New balloon could save dialysis patients from repeat surgeries

NCT ID NCT06639451

Ongoing Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special balloon coated with the drug paclitaxel to treat blockages in arm fistulas used for dialysis. The balloon is inflated to open the narrowed blood vessel and release the drug to help keep it open. Researchers will check if the fistula stays open without needing another procedure for at least 6 months in 186 adults on dialysis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: paclitaxel-coated balloon catheter
What this could lead to: If it works, this could provide a better way to keep dialysis fistulas open longer, reducing the need for repeat procedures.
What could go wrong: This is a mid-stage study without a control group, so results may not prove superiority over standard care. The drug coating may carry risks like vessel damage or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS FISTULA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital arteriovenous fistula

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTERIOVENOUS FISTULA ARTERIOVENOUS FISTULA STENOSIS VASCULAR ACCESS

Contacts and locations

Locations

Kansai Rosai Hospital

Amagasaki, Hyōgo, Japan
Kishiwada Tokushukai Hospital

Kishiwada, Osaka, Japan
Osaka Keisatsu Hospital

Osaka, Osaka, Japan
Saiseikai Central Hospital

Minato, Tokyo, Japan
Saitama Medical Center

Kawagoe, Saitama, Japan
Shizuoka General Hospital

Shizuoka, Shizuoka, Japan
Wakayama Medical University Hospital

Wakayama, Wakayama, Japan
Yokohama Dai-ichi Hospital

Yokohama, Kanagawa, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.